These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1673543)

  • 1. Response to beta-blockers in maternal and fetal rat hearts in vitro.
    Shen JJ; Wanwimolruk S; Mills RG; Roberts MS
    Life Sci; 1991; 48(18):1737-43. PubMed ID: 1673543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta blockers inhibit fetal thromboxane A2 production in vitro.
    Viinikka L; Ylikorkala O
    Biol Neonate; 1988; 54(3):169-72. PubMed ID: 2905896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-adrenoceptor blockade by atenolol, metoprolol and propranolol in the anaesthetized cat.
    Lundgren B; Carlsson E; Herrmann I
    Eur J Pharmacol; 1979 May; 55(3):263-8. PubMed ID: 37096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of atenolol and some other beta-adrenoceptor blocking agents on norepinephrine-induced responses in isolated and perfused rat hearts.
    Nakasone J; Kato T; Noguchi K; Nagamine F; Sakanashi M
    Jpn J Pharmacol; 1988 Aug; 47(4):387-95. PubMed ID: 2903263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-blocker subtypes and risk of low birth weight in newborns.
    Duan L; Ng A; Chen W; Spencer HT; Lee MS
    J Clin Hypertens (Greenwich); 2018 Nov; 20(11):1603-1609. PubMed ID: 30267456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of chronic beta-blockade on the ischaemic myocardium: a comparative study with five drugs.
    Manning AS; Hearse DJ; Coltart DJ
    J Cardiovasc Pharmacol; 1982; 4(6):999-1005. PubMed ID: 6185795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preservation of membrane phospholipids by propranolol, pindolol, and metoprolol: a novel mechanism of action of beta-blockers.
    Liu XK; Engelman RM; Agrawal HR; Das DK
    J Mol Cell Cardiol; 1991 Oct; 23(10):1091-100. PubMed ID: 1684206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The alpha- and beta-adrenoceptor blocking activities of labetalol and its RR-SR (50:50) stereoisomers.
    Riva E; Mennini T; Latini R
    Br J Pharmacol; 1991 Dec; 104(4):823-8. PubMed ID: 1687367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The selectivity of beta-adrenoceptor antagonists on isoprenaline-induced changes in heart rate, blood pressure, soleus muscle contractility and airways function in anaesthetized cats.
    Letts LG; Richardson DP; Temple DM; Williams LR
    Br J Pharmacol; 1983 Oct; 80(2):323-34. PubMed ID: 6140058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The central and peripheral components in the action of cardioselective beta-adrenoblockaders].
    Medvedev OS; Tiurmina OA
    Farmakol Toksikol; 1991; 54(3):30-2. PubMed ID: 1680750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta blocker effects on heart rate during sleep: a placebo-controlled polysomnographic study with normotensive males.
    Rosen RC; Kostis JB; Seltzer LG; Taska LS; Holzer BC
    Sleep; 1991 Feb; 14(1):43-7. PubMed ID: 1687425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atenolol, bufuralol and prizidilol are dual antagonists of the responses of the electrically driven rat right ventricle strip to isoprenaline.
    Doggrell SA
    Gen Pharmacol; 1989; 20(6):839-42. PubMed ID: 2574123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impairment of physical performance after treatment with beta blockers and alpha blockers.
    Bengtsson C
    Br Med J (Clin Res Ed); 1984 Mar; 288(6418):671-2. PubMed ID: 6141834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heart rate variability in rats with experimental chronic heart failure and long-term exposure to beta-adrenoblockers.
    Sal'nikov EV
    Bull Exp Biol Med; 2009 Feb; 147(2):181-4. PubMed ID: 19513416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockade of isoprenaline-induced changes in plasma free fatty acids, immunoreactive insulin levels and plasma renin activity in healthy human subjects, by propranolol, pindolol, practolol, atenolol, metoprolol and acebutolol.
    Harms HH; Gooren L; Spoelstra AJ; Hesse C; Verschoor L
    Br J Clin Pharmacol; 1978 Jan; 5(1):19-26. PubMed ID: 23133
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cholinergic antagonism by beta-blockers. I. Spectrum of interactions].
    Re L; Giorgetti F; Rossini L
    Boll Soc Ital Biol Sper; 1980 May; 56(9):892-8. PubMed ID: 6108773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relevance of selectivity and non-selectivity in beta-adrenoceptor blocking drugs.
    Bonelli J
    Br J Clin Pharmacol; 1982; 13(Suppl 2):199S-200S. PubMed ID: 6125170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic-pharmacodynamic modelling of S(-)-atenolol in rats: reduction of isoprenaline-induced tachycardia as a continuous pharmacodynamic endpoint.
    van Steeg TJ; Freijer J; Danhof M; de Lange EC
    Br J Pharmacol; 2007 Jun; 151(3):356-66. PubMed ID: 17420778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cholinergic antagonism by beta-blockers. II. Sequence of interactions and final steady state effects].
    Re L; Rossini L
    Boll Soc Ital Biol Sper; 1980 May; 56(9):899-904. PubMed ID: 6108774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of abrupt withdrawal of chronically administered beta-blocking drugs on cardiac sensitivity in the rat.
    Botting JH; Crook P
    Experientia; 1981 Dec; 37(12):1320-2. PubMed ID: 6120090
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.